These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18703301)

  • 21. Cost-effectiveness of coronary CT angiography in evaluation of patients without symptoms who have positive stress test results.
    Halpern EJ; Savage MP; Fischman DL; Levin DC
    AJR Am J Roentgenol; 2010 May; 194(5):1257-62. PubMed ID: 20410412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy and prognostic implications of stress testing for coronary artery disease in the elderly.
    Gentile R; Vitarelli A; Schillaci O; Laganà B; Gianni C; Rossi-Fanelli F; Fedele F
    Ital Heart J; 2001 Jul; 2(7):539-45. PubMed ID: 11501963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated stress real-time myocardial contrast echocardiography for the detection of coronary artery disease: comparison with 99mTc single photon emission computed tomography.
    Lipiec P; Wejner-Mik P; Krzemińska-Pakuła M; Kuśmierek J; Płachcińska A; Szumiński R; Peruga JZ; Kasprzak JD
    J Am Soc Echocardiogr; 2008 Aug; 21(8):941-7. PubMed ID: 18385014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Will robust evidence drive appropriate utilization of CTA?
    Wann S; Shaw LJ
    J Cardiovasc Comput Tomogr; 2007 Jul; 1(1):27-8. PubMed ID: 19083873
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results.
    Lee DS; Jang MJ; Cheon GJ; Chung JK; Lee MC
    J Nucl Cardiol; 2002; 9(5):515-22. PubMed ID: 12360132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Cost-Effectiveness of Diagnostic Tests for Assessing Stable Chest Pain: Modeled Analysis of Anatomical and Functional Strategies.
    Bertoldi EG; Stella SF; Rohde LE; Polanczyk CA
    Clin Cardiol; 2016 May; 39(5):249-56. PubMed ID: 27080921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of myocardial perfusion scintigraphy in the diagnosis and management of angina and myocardial infarction: a probabilistic economic analysis.
    Hernández R; Vale L
    Med Decis Making; 2007; 27(6):772-88. PubMed ID: 17989429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular opacification for the diagnosis of coronary artery disease with stress echocardiography: an angiographic study of incremental benefit and cost-effectiveness.
    Moir S; Shaw L; Haluska B; Jenkins C; Marwick TH
    Am Heart J; 2007 Sep; 154(3):510-8. PubMed ID: 17719299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease.
    Janzon M; Levin LA; Swahn E
    Eur Heart J; 2002 Jan; 23(1):31-40. PubMed ID: 11741360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic analysis including long-term risks and costs of alternative diagnostic strategies to evaluate patients with chest pain.
    Bedetti G; Pasanisi EM; Pizzi C; Turchetti G; Loré C
    Cardiovasc Ultrasound; 2008 May; 6():21. PubMed ID: 18510723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of exercise treadmill ECG versus stress SPECT myocardial perfusion imaging as an initial diagnostic strategy in stable patients with chest pain and suspected CAD: cost analysis.
    Sabharwal NK; Stoykova B; Taneja AK; Lahiri A
    J Nucl Cardiol; 2007 Apr; 14(2):174-86. PubMed ID: 17386379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany.
    Boldt J; Leber AW; Bonaventura K; Sohns C; Stula M; Huppertz A; Haverkamp W; Dorenkamp M
    J Cardiovasc Magn Reson; 2013 Apr; 15(1):30. PubMed ID: 23574690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease.
    Mark DB; Federspiel JJ; Cowper PA; Anstrom KJ; Hoffmann U; Patel MR; Davidson-Ray L; Daniels MR; Cooper LS; Knight JD; Lee KL; Douglas PS;
    Ann Intern Med; 2016 Jul; 165(2):94-102. PubMed ID: 27214597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of diagnostic evaluation strategies for individuals with stable chest pain syndrome and suspected coronary artery disease.
    Min JK; Gilmore A; Jones EC; Berman DS; Stuijfzand WJ; Shaw LJ; O'Day K; Danad I
    Clin Imaging; 2017; 43():97-105. PubMed ID: 28273654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: a model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods.
    Rumberger JA; Behrenbeck T; Breen JF; Sheedy PF
    J Am Coll Cardiol; 1999 Feb; 33(2):453-62. PubMed ID: 9973026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of anatomical and functional test strategies for stable chest pain: public health perspective from a middle-income country.
    Bertoldi EG; Stella SF; Rohde LEP; Polanczyk CA
    BMJ Open; 2017 May; 7(4):e012652. PubMed ID: 28473507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-impact of cardiac magnetic resonance imaging with Fast-SENC compared to SPECT in the diagnosis of coronary artery disease in the U.S.
    Stojanovic I; Schneider JE; Cooper J
    J Med Econ; 2019 May; 22(5):430-438. PubMed ID: 30732489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: mid-term outcomes from the CECaT randomised controlled trial.
    Thom H; West NE; Hughes V; Dyer M; Buxton M; Sharples LD; Jackson CH; Crean AM;
    BMJ Open; 2014 Feb; 4(2):e003419. PubMed ID: 24508847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economics of myocardial perfusion imaging in Europe--the EMPIRE Study.
    Underwood SR; Godman B; Salyani S; Ogle JR; Ell PJ
    Eur Heart J; 1999 Jan; 20(2):157-66. PubMed ID: 10099913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.
    Hayashino Y; Nagata-Kobayashi S; Morimoto T; Maeda K; Shimbo T; Fukui T
    J Gen Intern Med; 2004 Dec; 19(12):1181-91. PubMed ID: 15610328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.